Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thrombotic Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07228663
What this trial is testing

Hip Fracture Surgery Arterial and Venous Thrombotic Events Prevention

Who this might be right for
Hip Fracture SurgeryCardiovascular PreventionVenous Thromboembolism (VTE)
McMaster University 100
Post-approval studies (Phase 4)Study completedNCT02383355
What this trial is testing

Effects of Raltegravir Based Regimen on Platelet Reactivity, Platelet-monocyte Aggregation and Immune Activation

Who this might be right for
HIV
Radboud University Medical Center 40
Not applicableWithdrawnNCT01864512
What this trial is testing

Alteration of Different Immune Parameters in Immune Thrombocytopenia （ITP） Patients Receiving Eltrombopag Treatment

Who this might be right for
Immune Thrombocytopenia
Shandong University
Not applicableApproved For MarketingNCT04247906
What this trial is testing

Single Patient Expanded Access Treatment Plan For The Investigational Product Narsoplimab

Who this might be right for
Hematopoietic Stem Cell Transplant Associated Thrombotic Microangiopathy (HSCT-TMA)
Omeros Corporation
Early research (Phase 1)Ended earlyNCT00571467
What this trial is testing

Phase I Safety and Tolerability Study of Staphylococcal Protein A in Adult Patients With Chronic ITP

Who this might be right for
Idiopathic Thrombocytopenic Purpura (ITP)
Protalex, Inc. 9
Testing effectiveness (Phase 2)Study completedNCT00005652
What this trial is testing

Phase II Study of Rituximab in Patients With Immune Thrombocytopenic Purpura

Who this might be right for
Purpura, Thrombocytopenic, Idiopathic
University of Alabama at Birmingham 20
Not applicableStudy completedNCT03412188
What this trial is testing

The Effect of Eltrombopag on the Expression of Platelet Collagen Receptor GPVI in Pediatric ITP.

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Nayera Hazaa Elsherif 36
Not applicableStudy completedNCT04539678
What this trial is testing

SYTHROM Cohort, Myeloproliferative Neoplasia With Normal CBC and Thrombotic Complications

Who this might be right for
Thrombotic PatientsDiagnosis of Myeloproliferative NeoplasiaImpact of Treatment With Cytoreducing Agent
Nantes University Hospital 253
Testing effectiveness (Phase 2)Study completedNCT00844844
What this trial is testing

Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Resistant aHUS

Who this might be right for
Atypical Hemolytic Uremic Syndrome
Alexion Pharmaceuticals, Inc. 1
Early research (Phase 1)Not Yet RecruitingNCT07765966
What this trial is testing

Phase 1 Dose Escalation Study of RXIM002 in Autoimmune Cytopenias

Who this might be right for
Immune Thrombocytopenia (ITP)
RiboX Therapeutics Ltd. 27
Not applicableWithdrawnNCT01443351
What this trial is testing

Long-term Safety Study of Treatment With the Thrombopoietin Agonists Eltrombopag and Romiplostim in Patients With Immune Thrombocytopenia (ITP)

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Zealand University Hospital
Not applicableStudy completedNCT01719692
What this trial is testing

Low-dose Rituximab Regimens in Chinese Adult Patients With Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenic Purpura
Institute of Hematology & Blood Diseases Hospital, China 100
Not applicableUnknownNCT06275139
What this trial is testing

Integrated Assessment of Cervicocerebral Vessels to Improve the Brain Injury for CAGB Patients (IACV Study)

Who this might be right for
Coronary DiseaseCoronary Artery BypassStrokes Thrombotic
China National Center for Cardiovascular Diseases 348
Not applicableWithdrawnNCT04970004
What this trial is testing

Study in Adult and Pediatric Patients With HSCT-TMA

Who this might be right for
Stem Cell Transplant ComplicationsThrombotic Microangiopathies
Alexion Pharmaceuticals, Inc.
Not applicableUnknownNCT03187652
What this trial is testing

A Prospective Study on the Long-Term Vascular Burden in Thrombotic Thrombocytopenic Purpura Patients

Who this might be right for
Thrombotic Thrombocytopenic Purpura
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 35
Testing effectiveness (Phase 2)Study completedNCT00475423
What this trial is testing

MabThera (Rituximab) in Patients With Idiopathic Thrombocytopenic Purpura.

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Hoffmann-La Roche 122
Testing effectiveness (Phase 2)UnknownNCT04352218
What this trial is testing

Safety Profile of PETALO CVS in the Treatment of Non-thrombotic Internal Jugular Vein Stenosis and Chronic Headache

Who this might be right for
HeadacheJugular Vein Occlusion
University of Catania 60
Testing effectiveness (Phase 2)WithdrawnNCT03965624
What this trial is testing

Efficacy and Safety of Ixazomib and Dexamethasone Refractory Autoimmune Cytopenia

Who this might be right for
Immune ThrombocytopeniaWarm Autoimmune Hemolytic Anemia
Assistance Publique - Hôpitaux de Paris
Post-approval studies (Phase 4)Looking for participantsNCT07111559
What this trial is testing

Lacunar Stroke hyperAcute Clinical Utilization of Novel Approach Regimens: Rt-PA vs. DAPT Randomised Clinical Trial

Who this might be right for
Lacunar StrokeStrokeIschemic Stroke
Nippon Medical School 500
Testing effectiveness (Phase 2)Study completedNCT00441090
What this trial is testing

Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP)

Who this might be right for
Chronic Idiopathic Thrombocytopenic PurpuraPurpura, Thrombocytopenic, Idiopathic
Eisai Inc. 64
Next Page